AXQ Capital’s Thermo Fisher Scientific TMO Stock Holding History

AXQ Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05M	Sell	2,104 -4,305	-67%	-$2.07M	0.11%	275
2026 Q1	$3.15M	Buy	6,409 +5,719	+829%	+$3.1M	0.41%	40
2025 Q4	$400K	Buy	+690	New	+$390K	0.09%	345
2025 Q3	–	Sell	-5,591	Closed	-$2.27M	–	820
2025 Q2	$2.27M	Buy	+5,591	New	+$2.34M	0.73%	4
2024 Q4	–	Sell	-2,648	Closed	-$1.64M	–	622
2024 Q3	$1.64M	Sell	2,648 -4,363	-62%	-$2.58M	0.49%	32
2024 Q2	$3.88M	Buy	7,011 +3,811	+119%	+$2.18M	0.91%	4
2024 Q1	$1.86M	Buy	3,200 +1,800	+129%	+$1.01M	0.45%	29
2023 Q4	$743K	Buy	+1,400	New	+$678K	0.2%	182
2023 Q3	–	Sell	-1,100	Closed	-$574K	–	595
2023 Q2	$574K	Buy	+1,100	New	+$594K	0.71%	16

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

AXQ Capital's TMO Position: Q2 2026 in Review

AXQ Capital reduced its Thermo Fisher Scientific (TMO) stake by 67% in Q2 2026, selling an estimated $2.07M and leaving 2,104 shares worth $1.05M. The position accounts for 0.11% of the portfolio, ranked #275.

AXQ Capital first reported a position in TMO in Q2 2023 and has held it in 9 quarters since. The position peaked at $3.88M in Q2 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

AXQ Capital held 2,104 shares of Thermo Fisher Scientific worth $1.05M as of Q2 2026.
AXQ Capital sold 4,305 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.07M.
Thermo Fisher Scientific made up 0.11% of AXQ Capital's portfolio in Q2 2026, its #275 holding.
AXQ Capital first reported a position in Thermo Fisher Scientific in Q2 2023 and has held it in 9 quarters since.
AXQ Capital's Thermo Fisher Scientific position peaked at $3.88M in Q2 2024.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.